Brief: Intrasense H1 EBITDA Loss Widens To EUR 991,000

Intrasense SA

12/10/2022 17:23

Oct 12 (Reuters) - INTRASENSE SA  ALINS.PA :
    * H1 EBITDA LOSS EUR 991,000 VERSUS LOSS EUR 470,000 YEAR
AGO
    * 2022 HALF-YEAR RESULTS: CONTINUATION OF THE GROUP'S GROWTH
MOMENTUM
    * H1 CONSOLIDATED REVENUE EUR 1.9 MILLION VERSUS EUR 1.8
MILLION
YEAR AGO
    * H1 NET LOSS EUR 1.9 MILLION VERSUS LOSS EUR 0.7 MILLION
YEAR AGO
    * OUTLOOK: STRATEGY OF GROWING MARKET SHARE, DEVELOPING
TARGETED
MARKETS TO CONTINUE IN COMING MONTHS
    * ANNOUNCES THE APPOINTMENT OF JULIEN COSTE TO THE POSITION
OF
GROUP ADMINISTRATIVE & FINANCIAL DIRECTOR REPLACING LIONEL SELTZ
    * OUTLOOK: CONFIDENT THAT WE WILL CONTINUE TO GROW IN THE
YEARS TO
COME
    * BRINGING MYRIAN INTO COMPLIANCE WITH THE NEW EUROPEAN
REGULATION
FOR MEDICAL DEVICES WILL ALLOW OBTAINING THE VALIDATION OF A
NEXT VERSION IN 2023
    * CASH AND CASH EQUIVALENTS REMAIN AT A HIGH LEVEL AND
AMOUNT TO
€2,580K AT 30 JUNE 2022
    * OUTLOOK: GROUP'S AMBITION ALSO TO KEEP DIVERSIFYING
MARKETING
GEOGRAPHIES, TO ASSERT LEADER POSITION IN MEDICAL IMAGING
SOFTWARE SOLUTIONS
    * OUTLOOK: NEW ONCOLOGY PRODUCT LINE PROTOTYPE TO BE TESTED
FROM
END 2022

Source text for Eikon:  ID:nNDL14DV1m 
Further company coverage:  ALINS.PA 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))